CAR T cells show promise in mesothelioma

被引：2
作者：
Killock, David
机构：
[1] Nature Reviews Clinical Oncology,
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2021年 / 18卷 / 09期
关键词：
D O I：
10.1038/s41571-021-00547-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：541 / 541
页数：1
相关论文
共 1 条
[1]   A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab [J].
Adusumilli, Prasad S. ;
Zauderer, Marjorie G. ;
Riviere, Isabelle ;
Solomon, Stephen B. ;
Rusch, Valerie W. ;
O'Cearbhaill, Roisin E. ;
Zhu, Amy ;
Cheema, Waseem ;
Chintala, Navin K. ;
Halton, Elizabeth ;
Pineda, John ;
Perez-Johnston, Rocio ;
Tan, Kay See ;
Daly, Bobby ;
Araujo Filho, Jose A. ;
Ngai, Daniel ;
McGee, Erin ;
Vincent, Alain ;
Diamonte, Claudia ;
Sauter, Jennifer L. ;
Modi, Shanu ;
Sikder, Devanjan ;
Senechal, Brigitte ;
Wang, Xiuyan ;
Travis, William D. ;
Gonen, Mithat ;
Rudin, Charles M. ;
Brentjens, Renier J. ;
Jones, David R. ;
Sadelain, Michel .
CANCER DISCOVERY, 2021, 11 (11) :2748-2763
1